MCID: LYM023
MIFTS: 30
|
Lymphatic System Cancer
Categories:
Cancer diseases, Immune diseases
|
|
MalaCards integrated aliases for Lymphatic System Cancer:Classifications:External Ids:
|
Disease Ontology
:
12
An immune system cancer that is located in the lymphatic system and is characterized by uncontrolled cellular proliferation of lymphoid tissue.
MalaCards based summary : Lymphatic System Cancer is related to lymphangiosarcoma and lymph node cancer. An important gene associated with Lymphatic System Cancer is ALK (ALK Receptor Tyrosine Kinase), and among its related pathways/superpathways are Immune response Fc epsilon RI pathway and NF-kappaB Signaling. The drugs Immunotoxins and Immunologic Factors have been mentioned in the context of this disorder. Affiliated tissues include lung, bone and lymph node, and related phenotypes are hematopoietic system and immune system |
MGI Mouse Phenotypes related to Lymphatic System Cancer:46
|
Drugs for Lymphatic System Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
Interventional clinical trials:
|
MalaCards organs/tissues related to Lymphatic System Cancer:41
Lung,
Bone,
Lymph Node,
T Cells,
B Cells,
Thymus,
Myeloid
The Foundational Model of Anatomy Ontology organs/tissues related to Lymphatic System Cancer:19
The Lymphatic System
|
|
Search
GEO
for disease gene expression data for Lymphatic System Cancer.
|
Pathways related to Lymphatic System Cancer according to GeneCards Suite gene sharing:
|
Cellular components related to Lymphatic System Cancer according to GeneCards Suite gene sharing:
Biological processes related to Lymphatic System Cancer according to GeneCards Suite gene sharing:
|
|